Markets
BIO

Allscripts Helps Community Hospital Attain Stage 6 on EMRAM - Analyst Blog

Berlin, MD-based Atlantic General Hospital, a client of Allscripts Healthcare Solutions Inc.MDRX , recently achieved Stage 6 on the HIMSS Analytics Electronic Medical Record Adoption Model (EMRAM) using Allscripts Sunrise acute electronic health record (EHR).

Notably, Stage 6 is the second-highest level obtainable on the HIMSS Analytics EMRAM. There are a total of eight stages (0-7) in the EMRAM process. Attaining Stage 6 reflects the organization's success in establishing clear goals for improving safety, while reducing unwanted errors and prioritizing IT implementations.

We believe that such recognitions earned by Allscripts' clients will help the company gain significant market traction going forward. It should also enhance visibility of the company's wide range of services, which, in turn, will drive demand for its other offerings.

In fact, Atlantic General Hospital has also reconfirmed its commitment to Allscripts by deploying additional Sunrise solutions: Sunrise Surgical Care, Sunrise Radiology, Sunrise Emergency Care and Sunrise Mobile MD II. The hospital also selected Allscripts EPSiTM to help it streamline its budgeting and decision support processes.

We note that the Allscripts Sunrise EHR platform is helping the company gain significant popularity among hospitals and healthcare systems. As the services offered by Allscripts are becoming popular, we believe that it will enhance the company's top-line growth opportunities.

We note that the company has been reporting regular contract wins and addition of new domestic and international clients. Notably, in 2014, Allscripts added nearly 800 new clients for its EHR and related solutions in total.

We believe that regular contract wins will help drive Allscripts' dwindling top line, which is a potent headwind for the company at present. Moreover, Allscripts has to counter stiff competition and face sluggishness in the international market, which adds to the woes.

Stocks to Consider

Currently, Allscripts carries a Zacks Rank #4 (Sell).

Better-ranked stocks in the broader medical sector include Bio-Rad laboratories Inc. BIO , Hospira Inc. HSP and Vascular Solutions Inc. VASC . All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

HOSPIRA INC (HSP): Free Stock Analysis Report

ALLSCRIPTS HLTH (MDRX): Free Stock Analysis Report

BIO-RAD LABS -A (BIO): Free Stock Analysis Report

VASCULAR SOLUTN (VASC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BIO MDRX

Other Topics

Stocks